Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection-Reference-Cited by-同舟云学术

Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection

Published:2016-02-01 Issue:3 Volume:59 Page:841-853
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

He Shanshan¹,Xiao Jingbo²,Dulcey Andrés E.²,Lin Billy¹,Rolt Adam²,Hu Zongyi¹,Hu Xin²,Wang Amy Q.²,Xu Xin²,Southall Noel²,Ferrer Marc²,Zheng Wei²,Liang T. Jake¹,Marugan Juan J.²

Affiliation:

1. Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States

2. Division of Pre-Clinical Innovations, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, United States

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b00752

Reference35 articles.

1. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies

2. Current and Future Therapies for Hepatitis C Virus Infection

3. Current progress in development of hepatitis C virus vaccines